In conclusion, PBRM1 gene abnormalities may play an important carcinogenic role in some gastric cancer subgroups and may affect their tumor immune activity, thereby influencing the clinicopathological and overall prognosis of GAC. The gene discussed is PBRM1; the disease is gastric cancer.